Navigation Links
ISTA Pharmaceuticals Files New Drug Application with U.S. FDA for Bepreve(TM)
Date:11/13/2008

on-historical matters are forward-looking statements. Without limiting the foregoing, but by way of example, statements contained in this press release related to the FDA's timely acceptance and approval of Bepreve, ISTA's belief that the FDA will review and take action on Bepreve within ten months of filing, ISTA's expectation of bringing a new product to market every 12 to 18 months and becoming the leading niche ophthalmic pharmaceutical company are forward-looking statements. Except as required by law, ISTA disclaims any intent or obligation to update any forward-looking statements. These forward-looking statements are based on ISTA's expectations as of the date of this press release and are subject to risks and uncertainties that could cause actual results to differ materially. Important factors that could cause actual results to differ from current expectations include, among others, delays and uncertainties related to the FDA or other regulatory agency approval or actions; uncertainties and risks regarding market acceptance of and demand for ISTA's approved products; and such other risks and uncertainties as detailed from time to time in ISTA's public filings with the U.S. Securities and Exchange Commission, including but not limited to ISTA's Annual Report on Form 10-K for the year ended December 31, 2007, and its most recent Quarterly Report on Form 10-Q for the quarter ended September 30, 2008.


'/>"/>
SOURCE ISTA Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. Memory Pharmaceuticals Reports Third Quarter 2008 Financial Results
2. Chemical Engineering Conference Highlights Energy, Biomedicine, Pharmaceuticals, Sustainability and Centennial
3. Potentia Pharmaceuticals Appoints Johanna M. Seddon, M.D. and Janet Stoltz Sunness, M.D. to Scientific Advisory Board
4. Nventa Biopharmaceuticals Announces Third Quarter 2008 Financial Results and Recent Corporate Highlights
5. Amylin Pharmaceuticals Announces Strategic Restructuring and Workforce Reduction
6. Trubion Pharmaceuticals Inc. Reports Third Quarter and Nine Months 2008 Results
7. Potentia Pharmaceuticals Drug Candidate for Age-Related Macular Degeneration Shows Positive Safety Profile in Phase I Clinical Trial
8. Transdel Pharmaceuticals, Inc. Retains The Investor Relations Group
9. Idenix Pharmaceuticals to Present at Deutsche Banks 2008 Biotech Boston Confab
10. Critical Pharmaceuticals Raise GBP650K
11. Onyx Pharmaceuticals Licenses Rights to Novel Targeted Oncology Agent From BTG International
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/30/2014)... The Global and China Electrical Insulating ... on the current state of the Electrical Insulating ... report provides a basic overview of the industry, ... market analysis and Chinese domestic market analysis are ... and competitive landscape of the market. A comparison ...
(Date:8/29/2014)... 29, 2014 The global companion ... in 2019. It is expected to grow at ... and was valued at $1.8 billion in 2013, ... Market Research. , For more information regarding analysis ... , The research report, titled “Companion Diagnostics Market ...
(Date:8/29/2014)... , Aug. 29, 2014 /PRNewswire/ - iCo Therapeutics ... today reported financial results for the six months ... are expressed in Canadian dollars and presented under ... Quarter 2014 Highlights , Announced top-line ... (VA) primary endpoint for subjects enrolled in the ...
(Date:8/29/2014)... Due to a misstatement posted by the Family ... Technology Center, LLC ( ASCTC ) was reported as an ... might benefit ALS patients. Because of ASCTC's exclusive focus ... and therapeutic applications, FRC listed ASCTC as one of several ... wish not to support research that requires the death of ...
Breaking Biology Technology:Electrical Insulating Varnish Market World, China Regional Analysis & 2020 Forecasts Available at DeepResearchReports.com 2Electrical Insulating Varnish Market World, China Regional Analysis & 2020 Forecasts Available at DeepResearchReports.com 3Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 2Companion Diagnostics Market to Hit $5.6 Billion in 2019: Transparency Market Research 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 2iCo Therapeutics Announces Second Quarter 2014 Financial Results 3iCo Therapeutics Announces Second Quarter 2014 Financial Results 4The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 2The Adult Stem Cell Technology Center, LLC Declines ALS Ice Bucket Challenge Donors Wishing to Support Ethical Research for New Stem Cell Therapies 3
... Calif., Oct. 22 Telik, Inc.,(Nasdaq: TELK ) ... will be held on Wednesday, November 5, 2008 at ... release earlier that day of the,company,s financial results for ... conference call will be accessible via Telik,s website at, ...
... 22 Dynamic Alert Limited,(OTC Bulletin Board: DYMC) ... the commercialization of medical cannabis-based,pharmaceutical products. Today the ... agreement to acquire all of the assets of ... Cannabis pioneer and political,activist Steven W. Kubby ...
... to build for the company,s key technologies, ... Bulletin Board: DSCI), a company specializing in advanced ... on its new,technologies have been accepted and will ... in Skin & Wound Care in Las Vegas. ...
Cached Biology Technology:Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado 2Dynamic Signs Asset Acquisition Deal With Cannex and Brings Onboard Leading Medical Cannabis Research Scientist Dr. Robert Melamede, Former Chairman of the Biology Department, University of Colorado 3Derma Sciences Announces Multiple Clinical Posters Featuring MEDIHONEY(R) and ALGICELL Ag(R) to be Presented at Upcoming Wound Care Conference 2Derma Sciences Announces Multiple Clinical Posters Featuring MEDIHONEY(R) and ALGICELL Ag(R) to be Presented at Upcoming Wound Care Conference 3Derma Sciences Announces Multiple Clinical Posters Featuring MEDIHONEY(R) and ALGICELL Ag(R) to be Presented at Upcoming Wound Care Conference 4
(Date:9/1/2014)... basic building block of DNAcould initiate fragile X syndrome, the most ... The Journal of Cell Biology . , ... on the X chromosome called fragile X mental retardation 1 ... men carry a so-called premutation, in which a series of DNA ... slightly longer than normal. These repeats are prone to even further ...
(Date:9/1/2014)... The week-long discussions and decisions of the Nomenclature Section ... Melbourne, Australia in July 2011. This meeting is held ... premier experts on the rules for naming algae, fungi ... rule book for naming the organisms they study. This ... Code of Nomenclature for algae, fungi, and plants, which ...
(Date:8/31/2014)... A fast-sensitive "electronic-nose" for sniffing the highly infectious bacteria ... stomach cramps, has been developed by a team at ... the research team has demonstrated that it is possible ... which would lead to rapid diagnosis of the ... could be possible to identify different strains of the ...
Breaking Biology News(10 mins):A nucleotide change could initiate fragile X syndrome 2Week-long meeting on naming algae, fungi, and plants recorded for posterity 2Scientists develop 'electronic nose' for rapid detection of C. diff infection 2
... HILL As vast and far-reaching as the worlds oceans ... to a study in the journal Science by researchers at ... The international team of scientists integrated global data from ... warming that threaten 20 different marine ecosystems, such as ...
... Ariz. -- If we wanted to create the ideal environmentally ... easy and economical to produce, and one that does not ... at Arizona State University intend to develop in a new ... clean fuel that produces no greenhouse gases. The ...
... 2008, 10 a.m.The Nanoscale Science, Engineering, and ... and Technology Council,s Committee on Technology ... Nanotechnology Initiatives (NNI) strategy for addressing priority ... (EHS) aspects of nanomaterials. The full ...
Cached Biology News:First map of threats to marine ecosystems shows all the world's oceans are affected 2Project focuses on production of hydrogen from bacteria and sunlight 2Project focuses on production of hydrogen from bacteria and sunlight 3Project focuses on production of hydrogen from bacteria and sunlight 4Strategy for nanotechnology-related environmental, health and safety research 2
... designed to stabilize the biomolecules during ... There are neither animal proteins ... a convenient 10 times solution in ... to other traditional lyophilizing additives such ...
... IS, a true benchtop incubator-shaker, has the smallest ... a footprint of 540 x 680 mm (W ... chamber (370 x 505 x 510mm). Available in ... IS is ideal for shaking applications requiring controlled ...
... The new TC-412 thermal cycler, flexible on your ... is a high performance, high sample throughput instrument ... , Flexible block format: The truly user-friendly ... exchanged in a matter of seconds without the ...
Request Info...
Biology Products: